Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection

Clinical Infectious Diseases

Volumn 53, Issue 4, 2011, Pages 326-333

  Han, Ke ^a,b   Ma, Huilai ^b   An, Xiangdong ^c   Su, Yang ^b   Chen, Jing ^b   Lian, Zhiyong ^c   Zhao, Jinhui ^b   Zhu, Bao Ping ^b   Fontaine, Robert E ^d   Feng, Zijian ^b   Zeng, Guang ^b  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Shenyang Center for Disease Control and Prevention   (China)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; METHYLPREDNISOLONE; OSELTAMIVIR; PYRAZOLONE;

2009 H1N1 INFLUENZA; BODY TEMPERATURE; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG DOSE INCREASE; FEMALE; FEVER; FLU LIKE SYNDROME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; STEROID THERAPY; TEMPERATURE;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHINA; DEXAMETHASONE; FEMALE; FEVER; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; KAPLAN-MEIER ESTIMATE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79961239723     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir398     Document Type: Review

References (50)

1. World Health Organization. Pandemic (H1N1) 2009-update 94. 2010. Available at: http://www.who.int/entity/csr/don/2010-04-01/en/index.html. Accessed 26 April 2010.
2. Ministry of Health of China. Update on prevention and control of pandemic (H1N1) influenza in China-March 2010. 2010. Available at: http://www.moh.gov. cn/publicfiles/business/htmlfiles/mohwsyjbgs/s3578/201004/46480.htm. Accessed 26 April 2010.
3. Fowlkes AL, Arguin P, Biggerstaff MS, et al. Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009. Clin Infect Dis 2011; 52:S60-S68.
4. Rodriguez A, Socias L, Guerrero JE, et al. Pandemic influenza A in the ICU: experience in Spain and Latin America GETGAG/SEMICYUC/(Spanish Work Group on Severe Pandemic Influenza A/SEMICYUC) [in Spanish]. Med Intensiva 2010; 34:87-94.
5. Fuhrman C, Bonmarin I, Paty AC, et al. Severe hospitalised 2009 pandemic influenza A (H1N1) cases in France, 1 July-15 November 2009. Euro Surveill 2010; 15:pii19463.
6. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-44.
7. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009; 302:1880-7.
8. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009; 302:1872-9.
9. Webb SA, Pettila V, Seppelt I, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl JMed 2009; 361:1925-34.
10. Ministry of Health of China. Pregnant women represented 13.7% of the deaths due to 2009 pandemic (H1N1) virus infection. 2009. Available at: http://www.moh.gov.cn/publicfiles/business/htmlfiles/H1N1/s10617/200912/45239. htm. Accessed 26 April 2010.
11. Denholm JT, Gordon CL, Johnson PD, et al. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust 2010; 192:84-6.
12. Ministry of Health of China. Diagnosis and treatment guidelines for pH1N1 influenza infections, 2010. Beijing: Ministry of Health of China, 2010.
13. Ma HL, He F, Wan JF, et al. Glucocorticoid and pyrazolone treatment of acute fever is a risk factor for critical and life-threatening human enterovirus 71 infection during an outbreak in China, 2008. Pediatr Infect Dis J; 2010; 29:524-29.
14. Ministry of Health of China. Guidelines for the clinical diagnosis and treatment of pandemic H1N1 influenza (Ver. 3; 12 October 2009) [in Chinese]. Available at: http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohwsyjbgs/ s9990/200910/43111.htm. Accessed 24 June 2011.
15. Challen K, Bright J, Bentley A, Walter D. Physiological-social score (PMEWS) vs. CURB-65 to triage pandemic influenza: a comparative validation study using community-acquired pneumonia as a proxy. BMC Health Serv Res 2007; 7:33.
16. Chen CM, Kong LZ. Preliminary guidelines for prevention and control of overweight and obesity among Chinese adults [in Chinese]. Beijing: Bureau of Disease Control, Ministry of Health, People's Republic of China, 2003.
17. Obesity Taskforce of China. Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25:97-102.
18. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9:493-504.
19. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:1-52.
20. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989; 11:954-63.
21. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200:492-500.
22. Chien YS, Su CP, Tsai HT, et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect Dis 2010; 60:168-74.
23. Liem NT, Tung CV, Hien ND, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009; 48:1639-46.
24. Cullen G, Martin J, O'Donnell J, et al. Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April-3 October 2009. Euro Surveill 2009; 14:pii19398.
25. Campbell A, Rodin R, Kropp R, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010; 182:349-55.
26. Zarychanski R, Stuart TL, Kumar A, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010; 182:257-64.
27. Kass EH, Lundgren MM, Finland M. The effect of adrenal steroids, corticotropin, and growth hormone on resistance to experimental infections. J Exp Med 1954; 99:89-104.
28. Eichelberger MC, Prince GA, Ottolini MG. influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor. Virology 2004; 322:300-7. (Pubitemid 38521144)
29. Xu T, Qiao J, Zhao L, et al. Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. Eur Respir J 2009; 33:852-60.
30. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 2007; 104:12479-81. (Pubitemid 47206163)
31. Wang GF, Li N, Wu YF, et al. The COX regression analysis on the use of corticosteroids in the treatment of SARS [in Chinese]. Zhonghua Yi Xue Za Zhi 2004; 84:1073-8.
32. Zhao Z, Zhang F, Xu M, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003; 52:715-20. (Pubitemid 36981482)
33. Auyeung TW, Lee JS, Lai WK, et al. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J Infect Dis 2005; 51:98-102. (Pubitemid 40984342)
34. Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008; 336:1006-9. (Pubitemid 351656093)
35. World Health Organization. Clinical management of human infection with new influenza A (H1N1) virus: initial guidance. 2009. Available at: http://www.emro.who.int/csr/h1n1/pdf/clinical-management-21-5-2009.pdf. Accessed 26 April 2010.
36. Wang M. Textbook of pediatrics [in Chinese], 5th ed. Beijing: People's Health Publishing House, 2002.
37. Ye R, Lu Z. Textbook of internal medicine [in Chinese], 5th ed. Beijing: People's Health Publishing House, 2002.
38. Yuan J, Liu Y, Yang Z, et al. Mycobacterium abscessus postinjection abscesses from extrinsic contamination of multiple-dose bottles of normal saline in a rural clinic. Int J Infect Dis 2009; 13: 537-42.
39. Ye W. Experiences of using ibuprofen and glucocorticoids to treat acute pediatric respiratory infections with high fever [in Chinese]. Clin Med China 2001;17:138-9.
40. Yu TA, Dong HL. Effect of prolonged use of dexamethasone, amidopyrine compound, and antibiotics for pediatric fever treatment on the repeated respiratory infections of children [in Chinese]. J Qilu Nurs 2002; 8:294.
41. Huang WP, Jiang TX, Hu AP, et al. et al. Clinical discussions on the use of dexamethasone for the supplemental treatment of fever due to acute respiratory infections among infants and children [in Chinese]. Foreign Med Treat 2009; 27:97.
42. Sun JL, Huang YZ, Liu T. Clinical observations of the effect of using glucocorticoids for treating 218 pediatric fever patients [in Chinese]. Chin J Med Nurs 2006; 3:29.
43. Wang ZG, Yang MC. Clinical observations of short-termuse of steroids post-surgery among 206 patients [in Chinese]. China Community Physicians 2009; 11:55.
44. Chen YL. Observation of the effect of supplemental use of ambroxol for treatment of bronchopneumonia among infants and children [in Chinese]. Mod J Integrated Tradit Chin West Med 2007; 16: 2855.
45. Feng L. Report on the use of ultrasonically nebulized ribovirin and dexamethasone for treating pneumonia among 40 infants and children [in Chinese]. Chin Gen Med Pract 2001; 2:911.
46. Li ZR, Li WW, Li H. Observation of the effect of using nebulized dexamethasone and chymotrypsin for the supplemental treatment of viral pneumonia [in Chinese]. J Chin Mod Pediatr 2005; 2:724.
47. Liu CX. Observation on the effect of using low-dose dexamethasone as a supplemental treatment for pneumonia among infants and children [in Chinese]. Qinghai Med J 2009; 39:14.
48. Ma WN, Li C. Use of glucocorticoids in the treatment of severe pneumonia [in Chinese]. Contemp Med 2009; 15:11-2.
49. Liu H, Wang H, Huang Y. Clinical study of glucocorticoid in the treatment of idiopathic interstitial pneumonia [in Chinese]. J Clin Pulmonol Med 2004; 9:137-9.
50. Lin H. Observation of using dexamethasone to treat acute pediatric respiratory infections with fever among 60 infants and children [in Chinese]. Mod J Integrated Tradit Chin West Med 2008; 17:3106-7.